Cargando…

A high-throughput neutralizing assay for antibodies and sera evaluation against Epstein-Barr virus

BACKGROUND: Epstein-Barr virus (EBV) is a wide-spread human herpesvirus that is highly associated with infectious mononucleosis and several malignancies. Evaluation of EBV neutralizing antibody titers is important for serological studies, vaccine development and monoclonal antibody screening. The tr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhong, Ling, Krummenacher, Claude, Zhang, Wanlin, Hong, Junping, Feng, Qisheng, Zhao, Qinjian, Chen, Yixin, Zeng, Mu-Sheng, Zeng, Yi-Xin, Xu, Miao, Zhang, Xiao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Methodology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9685953/ https://www.ncbi.nlm.nih.gov/pubmed/36424667 http://dx.doi.org/10.1186/s12985-022-01911-1

Ejemplares similares

Urgency and necessity of Epstein-Barr virus prophylactic vaccines
por: Zhong, Ling, et al.
Publicado: (2022)

Immunization With Fc-Based Recombinant Epstein–Barr Virus gp350 Elicits Potent Neutralizing Humoral Immune Response in a BALB/c Mice Model
por: Zhao, Bingchun, et al.
Publicado: (2018)

Neutralizing antibodies against EBV gp42 show potent in vivo protection and define novel epitopes
por: Wu, Qian, et al.
Publicado: (2023)

Development of an HSV-1 neutralization test with a glycoprotein D specific antibody for measurement of neutralizing antibody titer in human sera
por: Luo, Yong, et al.
Publicado: (2016)

A novel vaccine candidate based on chimeric virus-like particle displaying multiple conserved epitope peptides induced neutralizing antibodies against EBV infection
por: Zhang, Xiao, et al.
Publicado: (2020)

A high-throughput neutralizing assay for antibodies and sera against hepatitis E virus
por: Cai, Wei, et al.
Publicado: (2016)

Dose-Dependent Outcome of EBV Infection of Humanized Mice Based on Green Raji Unit (GRU) Doses
por: Chen, Haiwen, et al.
Publicado: (2021)

Association between Antibody Responses to Epstein-Barr Virus Glycoproteins, Neutralization of Infectivity, and the Risk of Nasopharyngeal Carcinoma
por: Zhu, Qian-Ying, et al.
Publicado: (2020)

A focus reduction neutralization assay for hepatitis C virus neutralizing antibodies
por: Fournier, Carole, et al.
Publicado: (2007)

Genome-wide profiling of Epstein-Barr virus integration by targeted sequencing in Epstein-Barr virus associated malignancies
por: Xu, Miao, et al.
Publicado: (2019)

CryoEM structure of the tegumented capsid of Epstein-Barr virus
por: Li, Zhihai, et al.
Publicado: (2020)

A potent and protective human neutralizing antibody targeting a novel vulnerable site of Epstein-Barr virus
por: Zhu, Qian-Ying, et al.
Publicado: (2021)

Detection of Epstein-Barr virus (EBV) in human lymphoma tissue by a novel microbial detection array
por: Tellez, Joseph, et al.
Publicado: (2014)

Epstein-Barr Virus (EBV) detection and typing by PCR: a contribution to diagnostic screening of EBV-positive Burkitt's lymphoma
por: Hassan, Rocío, et al.
Publicado: (2006)

Quantitative profiling of housekeeping and Epstein-Barr virus gene transcription in Burkitt lymphoma cell lines using an oligonucleotide microarray
por: Bernasconi, Michele, et al.
Publicado: (2006)

A high-throughput screening assay to identify inhibitory antibodies targeting alphavirus release
por: Ramjag, Anushka, et al.
Publicado: (2022)

A high throughput DNA extraction method with high yield and quality
por: Xin, Zhanguo, et al.
Publicado: (2012)

Evaluation of T-activated proteins as recall antigens to monitor Epstein–Barr virus and human cytomegalovirus-specific T cells in a clinical trial setting
por: Körber, Nina, et al.
Publicado: (2020)

The Status and Prospects of Epstein–Barr Virus Prophylactic Vaccine Development
por: Sun, Cong, et al.
Publicado: (2021)

An improved microtiter assay for evaluating anti-HIV-1 neutralizing antibodies from sera or plasma
por: Zhang, Chiyu, et al.
Publicado: (2003)

The Criteria to Confirm the Role of Epstein-Barr Virus in Nasopharyngeal Carcinoma Initiation
por: Gu, Ai-Di, et al.
Publicado: (2012)

High throughput RNAi assay optimization using adherent cell cytometry
por: Nabzdyk, Christoph S, et al.
Publicado: (2011)

A high-throughput seed germination assay for root parasitic plants
por: Pouvreau, Jean-Bernard, et al.
Publicado: (2013)

A Pentavalent Epstein-Barr Virus-Like Particle Vaccine Elicits High Titers of Neutralizing Antibodies against Epstein-Barr Virus Infection in Immunized Rabbits
por: Escalante, Gabriela M., et al.
Publicado: (2020)

Measurement of Epstein-Barr virus DNA load using a novel quantification standard containing two EBV DNA targets and SYBR Green I dye
por: Lay, Meav-Lang J, et al.
Publicado: (2010)

Epstein Barr Virus and Mycobacterium avium subsp. paratuberculosis peptides are recognized in sera and cerebrospinal fluid of MS patients
por: Mameli, Giuseppe, et al.
Publicado: (2016)

Epstein-Barr virus infection and persistence in nasopharyngeal epithelial cells
por: Tsang, Chi Man, et al.
Publicado: (2014)

Fluorescence ImmunoPrecipitation (FLIP): a Novel Assay for High-Throughput IP
por: Mita, Paolo, et al.
Publicado: (2016)

A high throughput assay of lichenase activity with Congo red dye in plants
por: Tyurin, Alexander A., et al.
Publicado: (2021)

Genomic assays for Epstein–Barr virus-positive gastric adenocarcinoma
por: Gulley, Margaret L
Publicado: (2015)

Development of an Improved Epstein-Barr Virus (EBV) Neutralizing Antibody Assay to Facilitate Development of a Prophylactic gp350-Subunit EBV Vaccine
por: Liu, Hui, et al.
Publicado: (2020)

High-throughput malaria serosurveillance using a one-step multiplex bead assay
por: Rogier, Eric, et al.
Publicado: (2019)

Induction of chemokine (C‐C motif) ligand 5 by Epstein–Barr virus infection enhances tumor angiogenesis in nasopharyngeal carcinoma
por: Ma, Wenlong, et al.
Publicado: (2018)

A piggyBac-based TANGO GFP assay for high throughput screening of GPCR ligands in live cells
por: Li, Fei, et al.
Publicado: (2019)

Optimization of a magnetic bead-based assay (MAGPIX(®)-Luminex) for immune surveillance of exposure to malaria using multiple Plasmodium antigens and sera from different endemic settings
por: Varela, Marie Louise, et al.
Publicado: (2018)

Interpreting the Epstein-Barr Virus (EBV) Epigenome Using High-Throughput Data
por: Arvey, Aaron, et al.
Publicado: (2013)

Evaluation of MERS-CoV Neutralizing Antibodies in Sera Using Live Virus Microneutralization Assay
por: Algaissi, Abdullah, et al.
Publicado: (2019)

Reliability of the Siemens Enzygnost and Novagnost Epstein–Barr Virus assays for routine laboratory diagnosis: agreement with clinical diagnosis and comparison with the Merifluor Epstein–Barr Virus immunofluorescence assay
por: Kreuzer, Christina, et al.
Publicado: (2013)

A Simple and High-Throughput ELISA-Based Neutralization Assay for the Determination of Anti-Flavivirus Neutralizing Antibodies
por: Balingit, Jean Claude, et al.
Publicado: (2020)

Protocol: High-throughput and quantitative assays of auxin and auxin precursors from minute tissue samples
por: Liu, Xing, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_fqsepm7tlhq3dp634l39h29pom